Neuronetics, Inc. (STIM)
STIM Stock Price Chart
Explore Neuronetics, Inc. interactive price chart. Choose custom timeframes to analyze STIM price movements and trends.
STIM Company Profile
Discover essential business fundamentals and corporate details for Neuronetics, Inc. (STIM) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
28 Jun 2018
Employees
716.00
Website
https://www.neurostar.comCEO
Keith J. Sullivan
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
STIM Financial Timeline
Browse a chronological timeline of Neuronetics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.11.
Earnings released on 5 Aug 2025
EPS came in at -$0.15 falling short of the estimated -$0.08 by -87.50%, while revenue for the quarter reached $38.11M , beating expectations by +0.69%.
Earnings released on 6 May 2025
EPS came in at -$0.21 falling short of the estimated -$0.13 by -61.54%, while revenue for the quarter reached $31.98M , missing expectations by -12.63%.
Earnings released on 4 Mar 2025
EPS came in at -$0.33 falling short of the estimated -$0.26 by -26.92%, while revenue for the quarter reached $22.49M , missing expectations by -21.90%.
Earnings released on 12 Nov 2024
EPS came in at -$0.29 falling short of the estimated -$0.23 by -26.09%, while revenue for the quarter reached $18.53M , missing expectations by -3.14%.
Earnings released on 12 Aug 2024
EPS came in at -$0.33 falling short of the estimated -$0.27 by -22.22%, while revenue for the quarter reached $16.45M , missing expectations by -11.80%.
Earnings released on 7 May 2024
EPS came in at -$0.27 surpassing the estimated -$0.33 by +18.18%, while revenue for the quarter reached $17.42M , beating expectations by +1.73%.
Earnings released on 5 Mar 2024
EPS came in at -$0.19 surpassing the estimated -$0.26 by +26.92%, while revenue for the quarter reached $20.31M , beating expectations by +2.34%.
Earnings released on 7 Nov 2023
EPS came in at -$0.33 falling short of the estimated -$0.30 by -10.00%, while revenue for the quarter reached $17.88M , missing expectations by -9.49%.
Earnings released on 8 Aug 2023
EPS came in at -$0.17 surpassing the estimated -$0.34 by +50.00%, while revenue for the quarter reached $17.61M , beating expectations by +1.32%.
Earnings released on 9 May 2023
EPS came in at -$0.38 surpassing the estimated -$0.39 by +2.56%, while revenue for the quarter reached $15.54M , beating expectations by +2.37%.
Earnings released on 7 Mar 2023
EPS came in at -$0.30 surpassing the estimated -$0.43 by +30.23%, while revenue for the quarter reached $18.20M , beating expectations by +8.19%.
Earnings released on 8 Nov 2022
EPS came in at -$0.28 surpassing the estimated -$0.44 by +36.36%, while revenue for the quarter reached $16.50M , beating expectations by +9.87%.
Earnings released on 2 Aug 2022
EPS came in at -$0.39 surpassing the estimated -$0.43 by +9.30%, while revenue for the quarter reached $16.33M , beating expectations by +5.64%.
Earnings released on 12 May 2022
EPS came in at -$0.41 matching the estimated -$0.41, while revenue for the quarter reached $14.18M , beating expectations by +5.36%.
Earnings released on 8 Mar 2022
EPS came in at -$0.29 surpassing the estimated -$0.33 by +12.12%, while revenue for the quarter reached $15.02M , beating expectations by +4.05%.
Earnings released on 9 Nov 2021
EPS came in at -$0.31 falling short of the estimated -$0.28 by -10.71%, while revenue for the quarter reached $13.80M , missing expectations by -8.43%.
Earnings released on 3 Aug 2021
EPS came in at -$0.29 falling short of the estimated -$0.24 by -20.83%, while revenue for the quarter reached $14.20M , meeting expectations.
Earnings released on 4 May 2021
EPS came in at -$0.31 surpassing the estimated -$0.33 by +6.06%, while revenue for the quarter reached $12.29M , meeting expectations.
Earnings released on 2 Mar 2021
EPS came in at -$0.19 surpassing the estimated -$0.25 by +24.00%, while revenue for the quarter reached $15.58M .
Earnings released on 2 Nov 2020
EPS came in at -$0.18 surpassing the estimated -$0.31 by +41.94%, while revenue for the quarter reached $12.45M , missing expectations by -26.32%.
STIM Stock Performance
Access detailed STIM performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.